Birge RB - Search Results

1

Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer.

Kasikara C, Davra V, Calianese D, Geng K, Spires TE, Quigley M, Wichroski M, Sriram G, Suarez-Lopez L, Yaffe MB, Kotenko SV, De Lorenzo MS, Birge RB. Kasikara C, et al. Among authors: birge rb. Cancer Res. 2019 May 15;79(10):2669-2683. doi: 10.1158/0008-5472.CAN-18-2614. Epub 2019 Mar 15. Cancer Res. 2019. PMID: 30877108

2

Phosphorylation of Crk on tyrosine 251 in the RT loop of the SH3C domain promotes Abl kinase transactivation.

Sriram G, Reichman C, Tunceroglu A, Kaushal N, Saleh T, Machida K, Mayer B, Ge Q, Li J, Hornbeck P, Kalodimos CG, Birge RB. Sriram G, et al. Among authors: birge rb. Oncogene. 2011 Nov 17;30(46):4645-55. doi: 10.1038/onc.2011.170. Epub 2011 May 23. Oncogene. 2011. PMID: 21602891 Free PMC article.

3

Emerging roles for crk in human cancer.

Sriram G, Birge RB. Sriram G, et al. Among authors: birge rb. Genes Cancer. 2010 Nov;1(11):1132-9. doi: 10.1177/1947601910397188. Genes Cancer. 2010. PMID: 21779437 Free PMC article.

4

Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII.

Jankowski W, Saleh T, Pai MT, Sriram G, Birge RB, Kalodimos CG. Jankowski W, et al. Among authors: birge rb. Nat Chem Biol. 2012 May 13;8(6):590-6. doi: 10.1038/nchembio.954. Nat Chem Biol. 2012. PMID: 22581121 Free PMC article.

5

Commentary: The carboxyl-terminal Crk SH3 domain: Regulatory strategies and new perspectives.

Sriram G, Birge RB. Sriram G, et al. Among authors: birge rb. FEBS Lett. 2012 Aug 14;586(17):2615-8. doi: 10.1016/j.febslet.2012.04.040. Epub 2012 May 2. FEBS Lett. 2012. PMID: 22710158 Free article. Review.

6

TAM receptors in apoptotic cell clearance, autoimmunity, and cancer.

Nguyen KQ, Tsou WI, Kotenko S, Birge RB. Nguyen KQ, et al. Among authors: birge rb. Autoimmunity. 2013 Aug;46(5):294-7. doi: 10.3109/08916934.2013.794515. Epub 2013 May 10. Autoimmunity. 2013. PMID: 23662598 Free article. Review.

7

Crk at the quarter century mark: perspectives in signaling and cancer.

Kumar S, Fajardo JE, Birge RB, Sriram G. Kumar S, et al. Among authors: birge rb. J Cell Biochem. 2014 May;115(5):819-25. doi: 10.1002/jcb.24749. J Cell Biochem. 2014. PMID: 24356912

8

Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.

Tsou WI, Nguyen KQ, Calarese DA, Garforth SJ, Antes AL, Smirnov SV, Almo SC, Birge RB, Kotenko SV. Tsou WI, et al. Among authors: birge rb. J Biol Chem. 2014 Sep 12;289(37):25750-63. doi: 10.1074/jbc.M114.569020. Epub 2014 Jul 29. J Biol Chem. 2014. PMID: 25074926 Free PMC article.

9

Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity.

Nguyen KQ, Tsou WI, Calarese DA, Kimani SG, Singh S, Hsieh S, Liu Y, Lu B, Wu Y, Garforth SJ, Almo SC, Kotenko SV, Birge RB. Nguyen KQ, et al. Among authors: birge rb. J Biol Chem. 2014 Sep 12;289(37):25737-49. doi: 10.1074/jbc.M114.570838. Epub 2014 Jul 29. J Biol Chem. 2014. PMID: 25074939 Free PMC article.

10

Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk.

Sriram G, Jankowski W, Kasikara C, Reichman C, Saleh T, Nguyen KQ, Li J, Hornbeck P, Machida K, Liu T, Li H, Kalodimos CG, Birge RB. Sriram G, et al. Among authors: birge rb. Oncogene. 2015 Aug 6;34(32):4260-9. doi: 10.1038/onc.2014.361. Epub 2014 Nov 10. Oncogene. 2015. PMID: 25381819 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters